Altered orbitofrontal and pars opercularis cortical thickness in betel quid dependence chewers.
Saved in:
| Title: | Altered orbitofrontal and pars opercularis cortical thickness in betel quid dependence chewers. |
|---|---|
| Authors: | Fu LL; Department of Radiology, Hainan General Hospital (Hainan Afliated Hospital of Hainan Medical University), Haikou, Hainan, China., Chen HJ; Department of Radiology, Hainan General Hospital (Hainan Afliated Hospital of Hainan Medical University), Haikou, Hainan, China., Huang WY; Department of Radiology, Hainan General Hospital (Hainan Afliated Hospital of Hainan Medical University), Haikou, Hainan, China., Guo YH; Department of Radiology, Hainan General Hospital (Hainan Afliated Hospital of Hainan Medical University), Haikou, Hainan, China., Liu LT; Department of Radiology, Hainan General Hospital (Hainan Afliated Hospital of Hainan Medical University), Haikou, Hainan, China., Fu QQ; Department of Radiology, Hainan General Hospital (Hainan Afliated Hospital of Hainan Medical University), Haikou, Hainan, China., Qin HD; MR Research Collaboration, Siemens Healthineers, Guangzhou, China., Liu T; Department of Geriatric Center, Hainan General Hospital (Hainan Afliated Hospital of Hainan Medical University), Haikou, Hainan, China., Chen F; Department of Radiology, Hainan General Hospital (Hainan Afliated Hospital of Hainan Medical University), No. 19, Xiuhua Street, Xiuying District, Haikou 570311, Hainan,China. |
| Source: | Therapeutic advances in psychopharmacology [Ther Adv Psychopharmacol] 2024 Dec 06; Vol. 14, pp. 20451253241304219. Date of Electronic Publication: 2024 Dec 06 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Sage Country of Publication: England NLM ID: 101555693 Publication Model: eCollection Cited Medium: Print ISSN: 2045-1253 (Print) Linking ISSN: 20451253 NLM ISO Abbreviation: Ther Adv Psychopharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
